SCRS Talks
SCRS Talks, hosted by the Society for Clinical Research Sites (SCRS), is a platform for clinical research industry professionals to hear about valuable information shaping the research industry today. These short interviews will provide new perspectives and insights on pressing topics, current events, and the research community.
Show episodes
Join Dustin Owen, CEO of Elixia, as he discusses the company"s unique Clinical Site Organization (CSO) model and its role in successful clinical trials. With a focus on enhancing patient recruitment and delivering quality data, Elixia is reshaping how trials are managed in complex therapeutic areas like nephrology and
According to the Center for Information and Study on Clinical Research Participation (CISCRP), traveling to a clinical study is the top reason trial participation is disruptive for patients. Learn more about the complexities of patient travel in clinical trials and what the industry is doing about it with Chris Benevid
In this episode of SCRS Talks, we welcome Rob Hummel, COO and co-founder of Suvoda, to discuss Suvoda’s new role as an SCRS Global Impact Partner. Rob shares insights into Suvoda’s mission to simplify clinical trials for sites and patients through cutting-edge technology. He highlights how Suvoda’s integrated platform
Discover how patient-finding technology is revolutionizing the way sites identify eligible patients for research studies, streamlining manual processes, and unlocking the potential of electronic health records. Stephen Jasperse from IQVIA and Michal Janota from St. Anne"s University Hospital discuss the challenges and
In this episode, Dr. Christine Senn, Senior Vice President of Site/Sponsor Innovation at Advarra, explores the challenges of study startup and the risks posed by working in isolation. She emphasizes the power of moving from siloed processes to integrated collaborations between sponsors, CROs, and sites. Through real-wo
Rare disease trials come with unique challenges, and independent research sites are well-equipped to tackle them. Hamish Baird and Jennifer Botte of Remington-Davis discuss the role of independent sites in rare disease trials and their logistical and operational challenges when executing complex studies. Tune in to hea